The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

CRDF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.50%

Insider Buying (Last 12 Months): $102,900.00

Insider Selling (Last 12 Months): $0.00

Cardiff Oncology Insider Trading History Chart

Cardiff Oncology Share Price & Price History

^$1.60

▼ -0.06 (-3.61%)

As of 05/30/2023 06:22 PM ET

Days: 30 | 90 | 365

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

Cardiff Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2022	Mark Erlander	CEO	Buy	10,000	$1.43	$14,300.00	24,481
9/19/2022	Lale White	Director	Buy	15,000	$1.64	$24,600.00	113,788
9/16/2022	James E. Levine	CFO	Buy	30,000	$1.56	$46,800.00	60,000
9/15/2022	Renee P Tannenbaum	Director	Buy	10,000	$1.72	$17,200.00	10,000
9/21/2021	Gary W. Pace	Director	Buy	30,000	$6.75	$202,500.00
9/10/2021	James E. Levine	CFO	Buy	30,000	$6.47	$194,100.00	5,000
3/26/2021	Rodney S. Markin	Director	Buy	2,900	$10.32	$29,928.00	7,181
3/23/2021	Mark Erlander	CEO	Buy	965	$10.34	$9,978.10	14,481
3/23/2021	Vicki Kelemen	COO	Buy	960	$10.31	$9,897.60	6,053
3/22/2021	John P. Brancaccio	Director	Buy	3,000	$10.95	$32,850.00	12,260
3/18/2021	Gary W. Pace	Director	Buy	3,000	$10.55	$31,650.00	452,811
3/4/2021	Gary W. Pace	Director	Buy	1,500	$9.27	$13,905.00	451,811
9/16/2020	Gary W. Pace	Director	Buy	2,550	$5.70	$14,535.00	449,461

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Cardiff Oncology (NASDAQ:CRDF)

17.75% of Cardiff Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cardiff Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/15/2023	Two Sigma Advisers LP	143,500	$0.24M	0.0%	-23.2%	0.321%
5/15/2023	Two Sigma Investments LP	30,000	$50K	0.0%	+28.7%	0.067%
5/12/2023	Renaissance Technologies LLC	331,308	$0.55M	0.0%	-32.5%	0.742%
5/12/2023	BlackRock Inc.	757,818	$1.25M	0.0%	+1.1%	1.696%
5/12/2023	Bank of America Corp DE	79,918	$0.13M	0.0%	+145.0%	0.179%
5/12/2023	UBS Group AG	15,690	$26K	0.0%	+176.0%	0.035%
5/12/2023	Blair William & Co. IL	130,500	$0.22M	0.0%	-13.9%	0.292%
5/11/2023	Citigroup Inc.	651,161	$1.07M	0.0%	+651,061.0%	1.457%
5/4/2023	Denver Wealth Management Inc.	18,235	$30K	0.0%	N/A	0.041%
4/18/2023	Assenagon Asset Management S.A.	394,994	$0.65M	0.0%	+120.0%	0.884%
2/15/2023	Millennium Management LLC	140,767	$0.20M	0.0%	-29.5%	0.315%
2/15/2023	Morgan Stanley	280,766	$0.39M	0.0%	-25.5%	0.628%
2/14/2023	Two Sigma Investments LP	23,309	$33K	0.0%	N/A	0.052%
2/13/2023	Renaissance Technologies LLC	490,990	$0.69M	0.0%	+16.4%	1.099%
2/13/2023	GSA Capital Partners LLP	352,186	$0.49M	0.1%	+198.8%	0.788%
2/10/2023	Bank of America Corp DE	32,621	$46K	0.0%	-56.4%	0.073%
2/10/2023	Blair William & Co. IL	151,575	$0.21M	0.0%	-10.6%	0.339%
2/9/2023	Dimensional Fund Advisors LP	31,299	$44K	0.0%	-22.1%	0.070%
2/1/2023	Bank of Montreal Can	98,600	$0.14M	0.0%	N/A	0.221%
1/12/2023	Assenagon Asset Management S.A.	179,543	$0.25M	0.0%	+7.8%	0.402%
11/16/2022	Jane Street Group LLC	20,461	$32K	0.0%	N/A	0.046%
11/15/2022	Two Sigma Advisers LP	196,500	$0.30M	0.0%	-41.3%	0.440%
11/15/2022	Vanguard Group Inc.	1,942,048	$2.99M	0.0%	+10.6%	4.347%
11/15/2022	BlackRock Inc.	749,098	$1.15M	0.0%	+11.5%	1.677%
11/14/2022	Renaissance Technologies LLC	421,988	$0.65M	0.0%	-42.0%	0.945%
11/10/2022	Dimensional Fund Advisors LP	40,163	$62K	0.0%	+116.7%	0.090%
11/8/2022	Atom Investors LP	18,298	$28K	0.0%	-45.9%	0.041%
11/7/2022	Virtu Financial LLC	34,311	$53K	0.0%	+173.1%	0.079%
11/3/2022	Creative Planning	25,575	$39K	0.0%	N/A	0.059%
10/27/2022	Assenagon Asset Management S.A.	166,534	$0.26M	0.0%	+7.3%	0.385%
8/18/2022	Goldman Sachs Group Inc.	41,852	$92K	0.0%	-87.9%	0.097%
8/16/2022	Price T Rowe Associates Inc. MD	36,500	$80K	0.0%	+69.9%	0.084%
8/15/2022	AQR Capital Management LLC	54,580	$0.12M	0.0%	-85.0%	0.126%
8/15/2022	State Street Corp	139,945	$0.31M	0.0%	-80.1%	0.323%
8/15/2022	Laurion Capital Management LP	722,100	$1.59M	0.0%	N/A	1.667%
8/15/2022	Millennium Management LLC	393,603	$0.87M	0.0%	+38.1%	0.909%
8/13/2022	Renaissance Technologies LLC	727,616	$1.60M	0.0%	+48.1%	1.680%
8/12/2022	Northern Trust Corp	66,592	$0.15M	0.0%	-79.0%	0.154%
8/12/2022	LPL Financial LLC	26,384	$58K	0.0%	+17.9%	0.061%
8/1/2022	Chartwell Investment Partners LLC	296,507	$0.65M	0.0%	+266.1%	0.685%
7/27/2022	Assenagon Asset Management S.A.	155,190	$0.34M	0.0%	-52.2%	0.358%
6/7/2022	Bank of America Corp DE	16,465	$41K	0.0%	-62.6%	0.038%
5/27/2022	Walleye Capital LLC	123,305	$0.31M	0.0%	N/A	0.285%
5/17/2022	Walleye Capital LLC	123,305	$0.31M	0.0%	N/A	0.285%
5/17/2022	Quantbot Technologies LP	11,600	$28K	0.0%	N/A	0.027%
5/17/2022	Royal Bank of Canada	33,337	$83K	0.0%	-32.1%	0.077%
5/17/2022	Eventide Asset Management LLC	1,467,922	$3.64M	0.1%	-12.1%	3.389%
5/16/2022	Goldman Sachs Group Inc.	347,047	$0.86M	0.0%	-6.2%	0.801%
5/16/2022	State Street Corp	704,237	$1.75M	0.0%	+1.6%	1.626%
5/16/2022	Engineers Gate Manager LP	245,567	$0.61M	0.0%	N/A	0.567%
5/13/2022	Renaissance Technologies LLC	491,458	$1.22M	0.0%	N/A	1.135%
5/13/2022	Northern Trust Corp	317,858	$0.79M	0.0%	-6.3%	0.734%
5/13/2022	XTX Topco Ltd	25,154	$62K	0.0%	N/A	0.058%
5/13/2022	Vanguard Group Inc.	1,913,413	$4.75M	0.0%	-2.3%	4.418%
5/13/2022	Blair William & Co. IL	89,875	$0.22M	0.0%	-56.7%	0.208%
5/12/2022	BlackRock Inc.	2,496,120	$6.19M	0.0%	-1.4%	5.764%
5/11/2022	ACT Capital Management LLC	120,600	$0.30M	0.3%	+17.7%	0.278%
5/11/2022	GSA Capital Partners LLP	63,749	$0.16M	0.0%	+311.0%	0.147%
5/10/2022	Mercer Global Advisors Inc. ADV	147,857	$0.37M	0.0%	-21.5%	0.341%
5/9/2022	Principal Financial Group Inc.	54,691	$0.14M	0.0%	-31.9%	0.126%
4/25/2022	Assenagon Asset Management S.A.	324,460	$0.81M	0.0%	N/A	0.749%
2/15/2022	Chartwell Investment Partners LLC	77,607	$0.47M	0.0%	N/A	0.196%
2/15/2022	Kennedy Capital Management Inc.	170,447	$1.02M	0.0%	-3.1%	0.431%
2/14/2022	Altium Capital Management LP	337,000	$2.03M	0.6%	-3.4%	0.852%
2/14/2022	Point72 Asset Management L.P.	501,649	$3.02M	0.0%	N/A	1.268%
2/14/2022	Blair William & Co. IL	207,490	$1.25M	0.0%	-1.6%	0.525%
2/14/2022	GSA Capital Partners LLP	15,512	$93K	0.0%	N/A	0.039%
2/14/2022	Elkhorn Partners Limited Partnership	17,300	$0.10M	0.1%	+28.1%	0.044%
2/9/2022	Principal Financial Group Inc.	80,307	$0.48M	0.0%	-45.5%	0.203%
2/8/2022	Northern Trust Corp	339,081	$2.04M	0.0%	+4.7%	0.857%
2/7/2022	SG Americas Securities LLC	36,292	$0.22M	0.0%	-30.6%	0.092%
2/4/2022	Mercer Global Advisors Inc. ADV	188,357	$1.13M	0.0%	+8.7%	0.476%
11/17/2021	Altium Capital Management LP	348,888	$2.32M	0.5%	-30.5%	0.882%
11/16/2021	Janus Henderson Group PLC	3,533,381	$23.54M	0.0%	+12.1%	8.934%
11/16/2021	Two Sigma Advisers LP	700,800	$4.67M	0.0%	+5.4%	1.772%
11/16/2021	Two Sigma Investments LP	604,750	$4.03M	0.0%	-14.7%	1.529%
11/16/2021	Metropolitan Life Insurance Co NY	11,065	$74K	0.0%	N/A	0.028%
11/16/2021	Caxton Corp	2,522,083	$16.80M	13.6%	+7.6%	6.377%
11/15/2021	Marshall Wace LLP	18,769	$0.13M	0.0%	-92.6%	0.047%
11/15/2021	HighVista Strategies LLC	15,501	$0.10M	0.1%	N/A	0.039%
11/12/2021	The Manufacturers Life Insurance Company	24,853	$0.17M	0.0%	+10.4%	0.063%
11/12/2021	Geode Capital Management LLC	582,157	$3.88M	0.0%	+13.0%	1.472%
11/10/2021	Mercer Global Advisors Inc. ADV	173,357	$1.16M	0.0%	+3.3%	0.438%
11/10/2021	Goldman Sachs Group Inc.	357,672	$2.38M	0.0%	+333.4%	0.904%
11/9/2021	BlackRock Inc.	2,387,748	$15.90M	0.0%	+1.2%	6.037%
11/9/2021	Principal Financial Group Inc.	147,341	$0.98M	0.0%	-1.5%	0.373%
11/8/2021	State Board of Administration of Florida Retirement System	30,142	$0.20M	0.0%	+182.4%	0.076%
11/4/2021	Tortoise Investment Management LLC	15,000	$100K	0.0%	-25.0%	0.038%
11/4/2021	Deutsche Bank AG	245,964	$1.64M	0.0%	-23.5%	0.622%
11/2/2021	New York State Common Retirement Fund	15,868	$0.11M	0.0%	-48.6%	0.040%
11/1/2021	SG Americas Securities LLC	52,258	$0.35M	0.0%	N/A	0.132%
10/28/2021	WINTON GROUP Ltd	43,865	$0.29M	0.0%	+86.8%	0.111%
10/18/2021	Nisa Investment Advisors LLC	7,000	$47K	0.0%	N/A	0.018%
9/17/2021	Virtu Financial LLC	19,925	$0.13M	0.0%	-40.1%	0.050%
8/25/2021	Marshall Wace LLP	254,929	$1.70M	0.0%	N/A	0.645%
8/17/2021	Octagon Capital Advisors LP	982,753	$6.54M	1.4%	+51.2%	2.485%
8/17/2021	Caxton Corp	2,343,333	$15.58M	10.7%	+10.8%	5.925%
8/16/2021	Cubist Systematic Strategies LLC	47,344	$0.32M	0.0%	-48.6%	0.120%
8/16/2021	Opaleye Management Inc.	463,000	$3.08M	0.5%	-19.6%	1.171%
8/16/2021	California State Teachers Retirement System	49,946	$0.33M	0.0%	N/A	0.126%

Data available starting January 2016

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Today's Range

Now: $1.60

$1.58

$1.72

50 Day Range

MA: $1.63

$1.37

$1.95

52 Week Range

Now: $1.60

$1.20

$3.41

Volume

160,828 shs

Average Volume

215,903 shs

Market Capitalization

$71.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Who are the company insiders with the largest holdings of Cardiff Oncology?: Cardiff Oncology's top insider shareholders include:
Lale White (Director)
James E Levine (CFO)
Mark Erlander (CEO)
Renee P Tannenbaum (Director)
Gary W Pace (Director)
Learn More about top insider investors at Cardiff Oncology.
Who are the major institutional investors of Cardiff Oncology?: Cardiff Oncology's top institutional shareholders include:
BlackRock Inc. — 1.70%
Citigroup Inc. — 1.46%
Assenagon Asset Management S.A. — 0.88%
Renaissance Technologies LLC — 0.74%
Two Sigma Advisers LP — 0.32%
Blair William & Co. IL — 0.29%
Learn More about top institutional investors of Cardiff Oncology stock.
Which major investors are selling Cardiff Oncology stock?: In the last quarter, CRDF stock was sold by these institutional investors:
Renaissance Technologies LLC
Two Sigma Advisers LP
Blair William & Co. IL
Belvedere Trading LLC
Simplex Trading LLC
Which major investors are buying Cardiff Oncology stock?: During the previous quarter, CRDF stock was acquired by institutional investors including:
Citigroup Inc.
Assenagon Asset Management S.A.
Group One Trading L.P.
Bank of America Corp DE
Susquehanna International Group LLP
Denver Wealth Management Inc.
UBS Group AG
BlackRock Inc.
Within the previous year, these company insiders have bought Cardiff Oncology stock:
Lale White (Director)
James E Levine (CFO)
Mark Erlander (CEO)
Renee P Tannenbaum (Director)
Gary W Pace (Director)
Learn More investors buying Cardiff Oncology stock.